All News #Library
Others
Gilead`s Kite Erodes $2.3B Shoreline Cell Therapy Deal
03 Sep 2025 //
FIERCE BIOTECH
Shoreline Biosciences Names Mauro Avanzi Chief Medical Officer
21 Feb 2023 //
CONTRACT PHARMA
Shoreline Biosciences To Present Two Posters On Ink Cell Platform at NK2022
10 May 2022 //
PRNEWSWIRE
Dendreon and Shoreline Enter CMC Agreement
08 Nov 2021 //
CONTRACTPHARMA

Market Place
Sourcing Support